...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
【24h】

Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.

机译:预见造血祖细胞计数预测粒细胞 - 菌落刺激因子动员的CD34 +细胞产率在健康供体中的粒细胞刺激因子动员的外周血干细胞收获。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The hematopoietic progenitor cell (HPC) count measured by the Sysmex hematology analyzer can determine the timing for leukapheresis in autologous peripheral blood stem cell (PBSC) harvest. We evaluated whether a HPC count could predict CD34+ cell yield in healthy, unrelated donors after granulocyte-colony-stimulating factor mobilization. STUDY DESIGN AND METHODS: A total of 117 healthy donors underwent 161 PBSC leukapheresis procedures in our institution. The HPCs and CD34+ cells were identified by an automated hematology analyzer and flow cytometry, respectively. Using Spearman's rank test, we evaluated the relationships between preharvest HPCs, CD34+ cell counts, and CD34+ cell yields in the apheresis product. A receiver operating characteristic (ROC) curve analysis was used to identify the cutoff value of HPC for adequate mobilization and harvest yield. RESULTS: The HPC count had a moderate correlation with the preharvest CD34+ cell count (r = 0.502, p < 0.001), and an HPC count of more than 21.3 x 10(6)/L could exclude poor mobilization (<20 x 10(6) CD34+ cells/L) with sensitivity and specificity of 89.2 and 83.3%. However, the relationship between HPC count and CD34+ cell yield was not marked (r = 0.321, p < 0.001). The area under the curve for HPCs was significantly smaller than the preharvest CD34+ cell count on the ROC curve for predicting adequate harvest yield (>10 x 10(6) CD34+ cells/L of processed blood volume, 0.678 vs. 0.850, p = 0.001). CONCLUSION: Although the preapheresis HPC count could predict mobilization in healthy donors before leukapheresis, it may not be a superior index for predicting CD34+ cell yield compared with the preharvest CD34+ cell count.
机译:背景:Sysmex血液分析仪测量的造血祖细胞(HPC)计数可以确定自体外周血干细胞(PBSC)收获中白曲面睾丸睾丸的定时。我们评估了HPC计数是否可以在颗粒细胞 - 菌落刺激因子动员后预测HPC计数在健康的无关供体中的CD34 +细胞产率。研究设计和方法:在我们的机构中​​共有117名健康捐赠者接受了161磅PBSC白粉手术。通过自动血液分析仪和流式细胞术鉴定HPC和CD34 +细胞。使用Spearman的等级测试,我们评估了预接收HPC,CD34 +细胞计数和CD34 +细胞产量之间的关系。使用接收器操作特征(ROC)曲线分析来鉴定HPC的截止值以进行足够的动员和收获产量。结果:HPC计数与预烧制CD34 +电池计数(r = 0.502,p <0.001)具有中等的相关性,HPC计数超过21.3×10(6)/ l可以排除差的动员(<20 x 10( 6)CD34 +细胞/ L)具有89.2和83.3%的敏感性和特异性。然而,HPC计数和CD34 +电池产量之间的关系未标记(r = 0.321,p <0.001)。用于HPC曲线下的面积显着小于ROC曲线的预溶性CD34 +细胞计数,用于预测足够的收获产量(> 10×10(6)CD34 +细胞/ L的加工血容量,0.678 Vs.0.850,P = 0.001 )。结论:虽然预审HPC计数可以预测白皂孢杆菌前的健康供体中的动员,但与预充值CD34 +细胞计数相比,它可能不是预测CD34 +细胞产率的优越指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号